Literature DB >> 34518942

Interactions of Lipids, Lipoproteins, and Apolipoproteins with the Blood-Brain Barrier.

Elizabeth M Rhea1,2, William A Banks3,4.   

Abstract

Lipids and lipoproteins are a diverse group of substances and their interactions with the blood-brain barrier (BBB) is similarly diverse. Some lipoproteins such as high density lipoprotein (HDL), apolipoprotein (apo) A-I, apoJ, some free fatty acids, and triglycerides cross the BBB whereas others such as apoE do not. Some forms of cholesterol can cross the BBB and others do not. Lipids can have effects on BBB preservation and function: HDL may protect the BBB during multiple sclerosis, cholesterol can disrupt the BBB, and triglycerides inhibit the transport of leptin across the BBB and the activation of the hypothalamic leptin receptor. ApoE is associated with many effects on the BBB, with the specific isoform apoE4 having detrimental effects. In summary, the diverse ways in which lipids, lipoproteins, and apolipoproteins interact with the BBB is important in both health and disease.
© 2021. This is a U.S. government work and not under copyright protection in the U.S.; foreign copyright protection may apply.

Entities:  

Keywords:  HDL; apolipoprotein; apolipoprotein E; blood-brain barrier; cholesterol; lipids; lipoproteins; triglycerides

Mesh:

Substances:

Year:  2021        PMID: 34518942      PMCID: PMC8901411          DOI: 10.1007/s11095-021-03098-6

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  53 in total

1.  APOA1 polymorphism influences risk for early-onset nonfamiliar AD.

Authors:  Heike Vollbach; Reinhard Heun; Chris M Morris; Jim A Edwardson; Ian G McKeith; Frank Jessen; Anne Schulz; Wolfgang Maier; Heike Kölsch
Journal:  Ann Neurol       Date:  2005-09       Impact factor: 10.422

Review 2.  HDL and cholesterol handling in the brain.

Authors:  Cecilia Vitali; Cheryl L Wellington; Laura Calabresi
Journal:  Cardiovasc Res       Date:  2014-06-06       Impact factor: 10.787

Review 3.  Polyunsaturated fatty acids and their metabolites in brain function and disease.

Authors:  Richard P Bazinet; Sophie Layé
Journal:  Nat Rev Neurosci       Date:  2014-11-12       Impact factor: 34.870

4.  Fatty acid transport protein expression in human brain and potential role in fatty acid transport across human brain microvessel endothelial cells.

Authors:  Ryan W Mitchell; Ngoc H On; Marc R Del Bigio; Donald W Miller; Grant M Hatch
Journal:  J Neurochem       Date:  2011-03-31       Impact factor: 5.372

5.  Circulating triglycerides impact on orexigenic peptides and neuronal activity in hypothalamus.

Authors:  Guo-Qing Chang; Olga Karatayev; Zoya Davydova; Sarah F Leibowitz
Journal:  Endocrinology       Date:  2004-04-29       Impact factor: 4.736

6.  Triglycerides induce leptin resistance at the blood-brain barrier.

Authors:  William A Banks; Alan B Coon; Sandra M Robinson; Asif Moinuddin; Jessica M Shultz; Ryota Nakaoke; John E Morley
Journal:  Diabetes       Date:  2004-05       Impact factor: 9.461

7.  Mfsd2a is a transporter for the essential omega-3 fatty acid docosahexaenoic acid.

Authors:  Long N Nguyen; Dongliang Ma; Guanghou Shui; Peiyan Wong; Amaury Cazenave-Gassiot; Xiaodong Zhang; Markus R Wenk; Eyleen L K Goh; David L Silver
Journal:  Nature       Date:  2014-05-14       Impact factor: 49.962

8.  High-Density Lipoprotein Mimetic Peptide 4F Efficiently Crosses the Blood-Brain Barrier and Modulates Amyloid-β Distribution between Brain and Plasma.

Authors:  Suresh K Swaminathan; Andrew L Zhou; Kristen M Ahlschwede; Geoffry L Curran; Val J Lowe; Ling Li; Karunya K Kandimalla
Journal:  J Pharmacol Exp Ther       Date:  2020-08-10       Impact factor: 4.030

Review 9.  Docosahexaenoic Acid and Cognition throughout the Lifespan.

Authors:  Michael J Weiser; Christopher M Butt; M Hasan Mohajeri
Journal:  Nutrients       Date:  2016-02-17       Impact factor: 5.717

10.  Cerebrospinal fluid lipidomics: effects of an intravenous triglyceride infusion and apoE status.

Authors:  Angela J Hanson; William A Banks; Lisa F Bettcher; Robert Pepin; Daniel Raftery; Suzanne Craft
Journal:  Metabolomics       Date:  2019-12-12       Impact factor: 4.290

View more
  7 in total

Review 1.  Dietary fat: a potent microglial influencer.

Authors:  Alexis M Ceasrine; Staci D Bilbo
Journal:  Trends Endocrinol Metab       Date:  2022-01-22       Impact factor: 12.015

Review 2.  A Review of ApoE4 Interference Targeting Mitophagy Molecular Pathways for Alzheimer's Disease.

Authors:  Huiyi Chen; Feng Chen; Ying Jiang; Lu Zhang; Guizhen Hu; Furong Sun; Miaoping Zhang; Yao Ji; Yanting Chen; Gang Che; Xu Zhou; Yu Zhang
Journal:  Front Aging Neurosci       Date:  2022-05-20       Impact factor: 5.702

Review 3.  The Blood-Brain Barrier, Oxidative Stress, and Insulin Resistance.

Authors:  William A Banks; Elizabeth M Rhea
Journal:  Antioxidants (Basel)       Date:  2021-10-27

Review 4.  Connecting the Dots Between Hypercholesterolemia and Alzheimer's Disease: A Potential Mechanism Based on 27-Hydroxycholesterol.

Authors:  Mingan Wu; Yingying Zhai; Xiaoyi Liang; Weichun Chen; Ruiyi Lin; Linlin Ma; Yi Huang; Di Zhao; Yong Liang; Wei Zhao; Jiansong Fang; Shuhuan Fang; Yunbo Chen; Qi Wang; Weirong Li
Journal:  Front Neurosci       Date:  2022-04-07       Impact factor: 5.152

Review 5.  Relationship between Brain Metabolic Disorders and Cognitive Impairment: LDL Receptor Defect.

Authors:  Dong-Yong Hong; Dong-Hun Lee; Ji-Young Lee; Eun-Chae Lee; Sang-Won Park; Man-Ryul Lee; Jae-Sang Oh
Journal:  Int J Mol Sci       Date:  2022-07-29       Impact factor: 6.208

Review 6.  NADPH and Mitochondrial Quality Control as Targets for a Circadian-Based Fasting and Exercise Therapy for the Treatment of Parkinson's Disease.

Authors:  William M Curtis; William A Seeds; Mark P Mattson; Patrick C Bradshaw
Journal:  Cells       Date:  2022-08-04       Impact factor: 7.666

7.  The contribution of astrocytes to obesity-associated metabolic disturbances.

Authors:  Marta Obara-Michlewska
Journal:  J Biomed Res       Date:  2022-08-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.